Abstract
P-290 Updated long-term follow-up results of a phase 1b/2 study (FUMANBA-1) in patients with relapsed/refractory multiple myeloma (RRMM) treated with equecabtagene autoleucel
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have